| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 63 | 2025 | 691 | 14.210 |
Why?
|
| Pneumonia | 47 | 2024 | 290 | 10.920 |
Why?
|
| Hospitalization | 83 | 2025 | 1359 | 10.590 |
Why?
|
| Hospital Mortality | 68 | 2025 | 874 | 8.760 |
Why?
|
| Respiration, Artificial | 31 | 2024 | 297 | 7.330 |
Why?
|
| Hospitals | 36 | 2025 | 392 | 7.170 |
Why?
|
| Noninvasive Ventilation | 17 | 2024 | 70 | 6.020 |
Why?
|
| Patient Readmission | 41 | 2024 | 430 | 5.930 |
Why?
|
| Sepsis | 24 | 2022 | 286 | 5.790 |
Why?
|
| Anti-Bacterial Agents | 32 | 2025 | 785 | 5.630 |
Why?
|
| United States | 144 | 2025 | 7828 | 5.020 |
Why?
|
| Inpatients | 21 | 2023 | 303 | 4.990 |
Why?
|
| Quality of Health Care | 29 | 2024 | 519 | 4.660 |
Why?
|
| Retrospective Studies | 130 | 2025 | 6642 | 4.620 |
Why?
|
| Quality Indicators, Health Care | 19 | 2018 | 337 | 4.540 |
Why?
|
| Aged | 160 | 2025 | 14401 | 4.090 |
Why?
|
| Asthma | 14 | 2024 | 440 | 4.080 |
Why?
|
| Medicare | 26 | 2025 | 612 | 4.080 |
Why?
|
| Humans | 327 | 2025 | 63320 | 4.040 |
Why?
|
| Length of Stay | 48 | 2024 | 811 | 4.040 |
Why?
|
| Community-Acquired Infections | 17 | 2025 | 94 | 3.970 |
Why?
|
| Male | 203 | 2025 | 29841 | 3.770 |
Why?
|
| Female | 209 | 2025 | 32813 | 3.700 |
Why?
|
| Critical Illness | 12 | 2024 | 322 | 3.100 |
Why?
|
| Middle Aged | 127 | 2025 | 17563 | 3.010 |
Why?
|
| Practice Patterns, Physicians' | 17 | 2020 | 712 | 2.990 |
Why?
|
| Patient Discharge | 21 | 2025 | 511 | 2.970 |
Why?
|
| Cohort Studies | 57 | 2023 | 2569 | 2.940 |
Why?
|
| Heart Failure | 22 | 2025 | 915 | 2.870 |
Why?
|
| Patient Admission | 7 | 2018 | 197 | 2.800 |
Why?
|
| Aged, 80 and over | 71 | 2025 | 5449 | 2.740 |
Why?
|
| Risk Assessment | 24 | 2022 | 2077 | 2.660 |
Why?
|
| Pulmonary Embolism | 8 | 2024 | 172 | 2.650 |
Why?
|
| Shock, Septic | 8 | 2020 | 86 | 2.390 |
Why?
|
| Hospitalists | 14 | 2015 | 37 | 2.270 |
Why?
|
| Attitude of Health Personnel | 17 | 2019 | 595 | 2.250 |
Why?
|
| Pediatrics | 5 | 2019 | 254 | 2.170 |
Why?
|
| Physicians | 12 | 2019 | 470 | 2.120 |
Why?
|
| Respiratory Insufficiency | 8 | 2022 | 155 | 2.090 |
Why?
|
| Pneumonia, Bacterial | 7 | 2019 | 89 | 2.030 |
Why?
|
| Resuscitation Orders | 8 | 2024 | 48 | 2.000 |
Why?
|
| Sleep Apnea, Obstructive | 5 | 2018 | 57 | 2.000 |
Why?
|
| Treatment Outcome | 51 | 2025 | 5664 | 1.970 |
Why?
|
| Adult | 84 | 2025 | 16797 | 1.870 |
Why?
|
| Surgical Procedures, Operative | 9 | 2019 | 141 | 1.870 |
Why?
|
| Isotonic Solutions | 4 | 2015 | 14 | 1.850 |
Why?
|
| Choice Behavior | 4 | 2018 | 83 | 1.850 |
Why?
|
| Fluid Therapy | 4 | 2015 | 49 | 1.790 |
Why?
|
| Hospital Costs | 10 | 2019 | 126 | 1.760 |
Why?
|
| Quality Improvement | 9 | 2025 | 441 | 1.750 |
Why?
|
| Emergency Service, Hospital | 19 | 2024 | 1100 | 1.740 |
Why?
|
| Cross-Sectional Studies | 37 | 2024 | 2571 | 1.720 |
Why?
|
| International Classification of Diseases | 8 | 2021 | 136 | 1.720 |
Why?
|
| Cardiac Rehabilitation | 9 | 2022 | 67 | 1.710 |
Why?
|
| Smoking Cessation | 8 | 2025 | 550 | 1.710 |
Why?
|
| Minority Groups | 4 | 2024 | 139 | 1.650 |
Why?
|
| Smokers | 5 | 2025 | 119 | 1.620 |
Why?
|
| Patient Satisfaction | 12 | 2025 | 433 | 1.620 |
Why?
|
| Dyspnea | 5 | 2025 | 124 | 1.620 |
Why?
|
| Databases, Factual | 23 | 2021 | 872 | 1.560 |
Why?
|
| Poverty | 6 | 2025 | 296 | 1.550 |
Why?
|
| Disease Progression | 16 | 2025 | 1171 | 1.530 |
Why?
|
| Antimicrobial Stewardship | 3 | 2020 | 16 | 1.500 |
Why?
|
| Comorbidity | 26 | 2024 | 1123 | 1.500 |
Why?
|
| Patient Acceptance of Health Care | 10 | 2024 | 479 | 1.470 |
Why?
|
| Hospitals, Pediatric | 5 | 2019 | 52 | 1.450 |
Why?
|
| Internet | 7 | 2019 | 469 | 1.450 |
Why?
|
| Acute Disease | 19 | 2024 | 672 | 1.450 |
Why?
|
| Healthcare Disparities | 4 | 2024 | 359 | 1.380 |
Why?
|
| Logistic Models | 24 | 2023 | 1274 | 1.370 |
Why?
|
| Quality Assurance, Health Care | 8 | 2019 | 255 | 1.370 |
Why?
|
| Postoperative Complications | 11 | 2021 | 1306 | 1.340 |
Why?
|
| Heart Diseases | 5 | 2022 | 217 | 1.320 |
Why?
|
| Adolescent | 30 | 2024 | 6247 | 1.290 |
Why?
|
| Heparin, Low-Molecular-Weight | 3 | 2024 | 25 | 1.270 |
Why?
|
| Intensive Care Units | 11 | 2024 | 406 | 1.270 |
Why?
|
| Time Factors | 19 | 2021 | 3763 | 1.270 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2025 | 769 | 1.240 |
Why?
|
| Pneumonia, Aspiration | 3 | 2019 | 17 | 1.210 |
Why?
|
| Coronary Artery Bypass | 4 | 2019 | 297 | 1.210 |
Why?
|
| Decision Support Techniques | 3 | 2021 | 196 | 1.180 |
Why?
|
| Severity of Illness Index | 11 | 2018 | 1542 | 1.160 |
Why?
|
| Renal Colic | 2 | 2019 | 14 | 1.160 |
Why?
|
| Venous Thromboembolism | 6 | 2012 | 149 | 1.150 |
Why?
|
| Cross Infection | 6 | 2017 | 162 | 1.140 |
Why?
|
| Hospital Administrators | 3 | 2015 | 10 | 1.110 |
Why?
|
| Urology | 2 | 2019 | 45 | 1.110 |
Why?
|
| Risk Factors | 31 | 2021 | 5345 | 1.110 |
Why?
|
| Hospital Administration | 4 | 2013 | 43 | 1.090 |
Why?
|
| Health Services Accessibility | 5 | 2017 | 564 | 1.080 |
Why?
|
| Access to Information | 4 | 2015 | 30 | 1.070 |
Why?
|
| Clinical Coding | 4 | 2019 | 44 | 1.070 |
Why?
|
| Referral and Consultation | 5 | 2022 | 422 | 1.070 |
Why?
|
| Medical Staff, Hospital | 4 | 2018 | 57 | 1.060 |
Why?
|
| Coronary Disease | 2 | 2018 | 246 | 1.050 |
Why?
|
| Myocardial Infarction | 12 | 2021 | 913 | 1.030 |
Why?
|
| Child | 20 | 2024 | 4531 | 1.030 |
Why?
|
| Physician-Patient Relations | 8 | 2019 | 419 | 1.020 |
Why?
|
| Macrolides | 5 | 2022 | 38 | 1.020 |
Why?
|
| Tobacco Use Disorder | 2 | 2019 | 246 | 0.990 |
Why?
|
| Bronchodilator Agents | 4 | 2019 | 119 | 0.990 |
Why?
|
| Inappropriate Prescribing | 3 | 2025 | 66 | 0.980 |
Why?
|
| Guideline Adherence | 8 | 2024 | 305 | 0.960 |
Why?
|
| Health Resources | 3 | 2016 | 94 | 0.960 |
Why?
|
| Terminal Care | 4 | 2024 | 103 | 0.950 |
Why?
|
| Quality of Life | 13 | 2025 | 1225 | 0.920 |
Why?
|
| Young Adult | 22 | 2024 | 4687 | 0.920 |
Why?
|
| Critical Care | 8 | 2024 | 397 | 0.920 |
Why?
|
| Anticoagulants | 3 | 2024 | 495 | 0.920 |
Why?
|
| Practice Guidelines as Topic | 11 | 2021 | 734 | 0.910 |
Why?
|
| Bronchoconstriction | 2 | 2014 | 9 | 0.910 |
Why?
|
| Qualitative Research | 14 | 2025 | 684 | 0.910 |
Why?
|
| Dementia | 3 | 2023 | 260 | 0.910 |
Why?
|
| Propensity Score | 8 | 2024 | 160 | 0.910 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2019 | 181 | 0.900 |
Why?
|
| Patient Navigation | 2 | 2016 | 35 | 0.900 |
Why?
|
| Hospitals, Teaching | 6 | 2018 | 105 | 0.900 |
Why?
|
| Follow-Up Studies | 15 | 2019 | 2457 | 0.900 |
Why?
|
| Soft Tissue Infections | 2 | 2015 | 49 | 0.880 |
Why?
|
| Attitude | 2 | 2015 | 99 | 0.880 |
Why?
|
| Ambulatory Care | 4 | 2024 | 311 | 0.870 |
Why?
|
| Massachusetts | 18 | 2024 | 2076 | 0.870 |
Why?
|
| Ureterolithiasis | 2 | 2021 | 13 | 0.860 |
Why?
|
| Urinary Tract Infections | 2 | 2015 | 90 | 0.860 |
Why?
|
| Outpatients | 3 | 2023 | 142 | 0.860 |
Why?
|
| Benchmarking | 6 | 2018 | 137 | 0.860 |
Why?
|
| Surveys and Questionnaires | 16 | 2022 | 2676 | 0.850 |
Why?
|
| Perioperative Care | 5 | 2013 | 85 | 0.840 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2012 | 150 | 0.840 |
Why?
|
| Decision Making | 9 | 2019 | 407 | 0.830 |
Why?
|
| Glucocorticoids | 3 | 2015 | 188 | 0.830 |
Why?
|
| Primary Health Care | 4 | 2019 | 690 | 0.830 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 834 | 0.780 |
Why?
|
| Legionella | 1 | 2022 | 3 | 0.780 |
Why?
|
| Patient Participation | 9 | 2020 | 230 | 0.780 |
Why?
|
| Child, Preschool | 13 | 2024 | 1995 | 0.780 |
Why?
|
| Legionnaires' Disease | 1 | 2022 | 8 | 0.770 |
Why?
|
| Electronic Health Records | 7 | 2023 | 360 | 0.760 |
Why?
|
| Population Health | 1 | 2022 | 17 | 0.750 |
Why?
|
| Medicaid | 6 | 2024 | 362 | 0.750 |
Why?
|
| Drug Utilization | 4 | 2015 | 209 | 0.740 |
Why?
|
| Parents | 3 | 2018 | 392 | 0.740 |
Why?
|
| Age Factors | 14 | 2017 | 1558 | 0.730 |
Why?
|
| Treatment Failure | 6 | 2021 | 201 | 0.730 |
Why?
|
| Infant | 10 | 2023 | 1650 | 0.720 |
Why?
|
| Accountable Care Organizations | 4 | 2024 | 67 | 0.710 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2021 | 72 | 0.700 |
Why?
|
| Odds Ratio | 11 | 2021 | 768 | 0.690 |
Why?
|
| Cardiology Service, Hospital | 2 | 2018 | 17 | 0.680 |
Why?
|
| Patient Selection | 4 | 2025 | 488 | 0.680 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 74 | 0.670 |
Why?
|
| Delirium | 2 | 2013 | 54 | 0.650 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2020 | 34 | 0.650 |
Why?
|
| Artifacts | 1 | 2021 | 125 | 0.650 |
Why?
|
| Multivariate Analysis | 11 | 2017 | 936 | 0.650 |
Why?
|
| Amiodarone | 1 | 2019 | 21 | 0.630 |
Why?
|
| Intubation, Intratracheal | 2 | 2021 | 204 | 0.630 |
Why?
|
| Atrial Flutter | 1 | 2019 | 23 | 0.620 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 95 | 0.620 |
Why?
|
| Research Design | 4 | 2019 | 573 | 0.620 |
Why?
|
| Social Networking | 1 | 2019 | 23 | 0.610 |
Why?
|
| Unnecessary Procedures | 4 | 2014 | 49 | 0.610 |
Why?
|
| Administrative Personnel | 1 | 2019 | 31 | 0.610 |
Why?
|
| Professional Practice Location | 1 | 2018 | 12 | 0.600 |
Why?
|
| Health Care Surveys | 8 | 2017 | 286 | 0.590 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 99 | 0.590 |
Why?
|
| Pediatricians | 1 | 2019 | 52 | 0.590 |
Why?
|
| Liver Cirrhosis | 3 | 2014 | 171 | 0.590 |
Why?
|
| Clostridium Infections | 2 | 2022 | 49 | 0.590 |
Why?
|
| Information Dissemination | 2 | 2010 | 116 | 0.580 |
Why?
|
| Wound Healing | 1 | 2019 | 189 | 0.580 |
Why?
|
| Accidental Falls | 1 | 2019 | 127 | 0.580 |
Why?
|
| Betacoronavirus | 1 | 2020 | 183 | 0.580 |
Why?
|
| Reimbursement, Incentive | 2 | 2009 | 29 | 0.580 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 28 | 0.570 |
Why?
|
| Patient Transfer | 2 | 2016 | 93 | 0.570 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 163 | 0.570 |
Why?
|
| Resuscitation | 2 | 2015 | 71 | 0.570 |
Why?
|
| Transitional Care | 4 | 2019 | 25 | 0.570 |
Why?
|
| Echocardiography | 2 | 2018 | 500 | 0.560 |
Why?
|
| Calcitonin | 1 | 2017 | 17 | 0.560 |
Why?
|
| Quinolones | 3 | 2016 | 29 | 0.550 |
Why?
|
| Neoplasms | 7 | 2024 | 1361 | 0.550 |
Why?
|
| Nicotine | 1 | 2018 | 117 | 0.540 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2017 | 172 | 0.540 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 210 | 0.530 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 224 | 0.530 |
Why?
|
| Information Services | 1 | 2017 | 35 | 0.520 |
Why?
|
| Life Support Care | 1 | 2017 | 20 | 0.520 |
Why?
|
| Hospitals, Low-Volume | 1 | 2017 | 21 | 0.520 |
Why?
|
| Health Personnel | 3 | 2017 | 367 | 0.520 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2016 | 7 | 0.510 |
Why?
|
| Psychotic Disorders | 2 | 2021 | 158 | 0.510 |
Why?
|
| Hospitals, Rural | 2 | 2015 | 19 | 0.510 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 35 | 0.510 |
Why?
|
| Hospitals, General | 1 | 2016 | 17 | 0.510 |
Why?
|
| Hospitals, Urban | 2 | 2015 | 43 | 0.510 |
Why?
|
| Managed Care Programs | 1 | 2017 | 89 | 0.510 |
Why?
|
| Program Development | 2 | 2015 | 207 | 0.510 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 37 | 0.500 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2016 | 7 | 0.500 |
Why?
|
| Palliative Care | 5 | 2025 | 229 | 0.500 |
Why?
|
| Community Health Centers | 1 | 2017 | 92 | 0.500 |
Why?
|
| Veterans | 2 | 2022 | 765 | 0.500 |
Why?
|
| Risk Adjustment | 3 | 2013 | 94 | 0.500 |
Why?
|
| Health Facility Size | 1 | 2015 | 16 | 0.490 |
Why?
|
| Patient Care Team | 3 | 2017 | 337 | 0.490 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 60 | 0.490 |
Why?
|
| Residence Characteristics | 6 | 2022 | 220 | 0.490 |
Why?
|
| Patients | 4 | 2022 | 113 | 0.490 |
Why?
|
| Catheterization, Peripheral | 1 | 2016 | 53 | 0.480 |
Why?
|
| Patient Care Bundles | 1 | 2015 | 12 | 0.480 |
Why?
|
| Chronic Disease | 3 | 2017 | 753 | 0.480 |
Why?
|
| Specialization | 3 | 2024 | 81 | 0.480 |
Why?
|
| Sodium Chloride | 1 | 2015 | 63 | 0.480 |
Why?
|
| Infection Control | 1 | 2016 | 106 | 0.470 |
Why?
|
| Continuity of Patient Care | 3 | 2015 | 174 | 0.470 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 49 | 0.470 |
Why?
|
| Catheterization, Central Venous | 1 | 2016 | 87 | 0.470 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2012 | 62 | 0.470 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 95 | 0.470 |
Why?
|
| Health Services for Persons with Disabilities | 1 | 2015 | 2 | 0.470 |
Why?
|
| Defensive Medicine | 1 | 2014 | 3 | 0.460 |
Why?
|
| Clinical Decision-Making | 4 | 2021 | 165 | 0.460 |
Why?
|
| Self-Management | 3 | 2021 | 62 | 0.450 |
Why?
|
| Hypnotics and Sedatives | 2 | 2024 | 66 | 0.450 |
Why?
|
| Protein C | 3 | 2014 | 26 | 0.450 |
Why?
|
| Prevalence | 9 | 2024 | 1378 | 0.450 |
Why?
|
| Insurance, Health | 4 | 2024 | 152 | 0.450 |
Why?
|
| Workload | 3 | 2010 | 126 | 0.440 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 536 | 0.440 |
Why?
|
| Gastroenterology | 1 | 2014 | 42 | 0.440 |
Why?
|
| Hospital Medicine | 1 | 2014 | 6 | 0.430 |
Why?
|
| Ceftriaxone | 1 | 2014 | 19 | 0.430 |
Why?
|
| Hospital Information Systems | 1 | 2014 | 11 | 0.430 |
Why?
|
| Atrial Fibrillation | 2 | 2019 | 834 | 0.430 |
Why?
|
| Prognosis | 8 | 2019 | 1747 | 0.430 |
Why?
|
| Interviews as Topic | 6 | 2024 | 510 | 0.430 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2014 | 13 | 0.430 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 1616 | 0.420 |
Why?
|
| Mothers | 1 | 2017 | 275 | 0.420 |
Why?
|
| Self Report | 1 | 2016 | 375 | 0.420 |
Why?
|
| Patient Compliance | 4 | 2019 | 360 | 0.420 |
Why?
|
| Disease Management | 1 | 2015 | 232 | 0.410 |
Why?
|
| Pregnancy | 6 | 2017 | 2335 | 0.410 |
Why?
|
| Relative Value Scales | 1 | 2013 | 15 | 0.410 |
Why?
|
| Central Venous Catheters | 1 | 2013 | 17 | 0.410 |
Why?
|
| Social Media | 1 | 2015 | 128 | 0.400 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2013 | 10 | 0.400 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 40 | 0.400 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 310 | 0.400 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 209 | 0.400 |
Why?
|
| Efficiency, Organizational | 2 | 2013 | 96 | 0.400 |
Why?
|
| Smoking | 4 | 2019 | 866 | 0.400 |
Why?
|
| Patient Care | 2 | 2013 | 80 | 0.400 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 216 | 0.390 |
Why?
|
| Communication | 4 | 2013 | 571 | 0.390 |
Why?
|
| Defibrillators, Implantable | 1 | 2016 | 265 | 0.390 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 65 | 0.380 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 106 | 0.380 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 672 | 0.380 |
Why?
|
| Vasoconstrictor Agents | 4 | 2018 | 70 | 0.370 |
Why?
|
| Time and Motion Studies | 1 | 2011 | 18 | 0.370 |
Why?
|
| Survival Analysis | 3 | 2020 | 581 | 0.370 |
Why?
|
| Drug Therapy, Combination | 6 | 2020 | 463 | 0.370 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 118 | 0.370 |
Why?
|
| Physicians, Family | 3 | 2008 | 74 | 0.360 |
Why?
|
| Linear Models | 6 | 2021 | 409 | 0.360 |
Why?
|
| Health Surveys | 1 | 2013 | 313 | 0.360 |
Why?
|
| Interprofessional Relations | 3 | 2022 | 134 | 0.360 |
Why?
|
| Health Status Disparities | 1 | 2013 | 146 | 0.360 |
Why?
|
| Survival Rate | 6 | 2019 | 851 | 0.350 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 1650 | 0.350 |
Why?
|
| Models, Statistical | 5 | 2016 | 308 | 0.350 |
Why?
|
| Cost of Illness | 1 | 2012 | 162 | 0.350 |
Why?
|
| Insurance | 2 | 2024 | 18 | 0.350 |
Why?
|
| Data Collection | 7 | 2015 | 383 | 0.340 |
Why?
|
| Vulnerable Populations | 2 | 2025 | 90 | 0.340 |
Why?
|
| Hodgkin Disease | 2 | 2021 | 55 | 0.340 |
Why?
|
| Enoxaparin | 1 | 2010 | 18 | 0.340 |
Why?
|
| Disclosure | 1 | 2010 | 55 | 0.330 |
Why?
|
| Mortality | 5 | 2016 | 160 | 0.330 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 435 | 0.330 |
Why?
|
| Hypertension | 3 | 2017 | 585 | 0.330 |
Why?
|
| Child, Hospitalized | 2 | 2021 | 16 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 695 | 0.320 |
Why?
|
| Mandatory Reporting | 1 | 2009 | 16 | 0.320 |
Why?
|
| Influenza, Human | 2 | 2023 | 208 | 0.320 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 474 | 0.320 |
Why?
|
| Heparin | 3 | 2024 | 116 | 0.310 |
Why?
|
| California | 7 | 2017 | 174 | 0.310 |
Why?
|
| Motivation | 2 | 2025 | 284 | 0.300 |
Why?
|
| Comparative Effectiveness Research | 3 | 2014 | 46 | 0.300 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2020 | 36 | 0.300 |
Why?
|
| Fee-for-Service Plans | 3 | 2025 | 69 | 0.300 |
Why?
|
| Models, Biological | 1 | 2014 | 1177 | 0.300 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2021 | 126 | 0.290 |
Why?
|
| Walking | 2 | 2023 | 238 | 0.290 |
Why?
|
| Costs and Cost Analysis | 5 | 2023 | 102 | 0.290 |
Why?
|
| Emergency Medicine | 4 | 2019 | 189 | 0.290 |
Why?
|
| Perception | 2 | 2020 | 174 | 0.280 |
Why?
|
| Incidence | 6 | 2019 | 1376 | 0.280 |
Why?
|
| Stakeholder Participation | 2 | 2018 | 23 | 0.280 |
Why?
|
| Attitude to Computers | 2 | 2012 | 21 | 0.280 |
Why?
|
| Drug Utilization Review | 1 | 2008 | 52 | 0.280 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 301 | 0.280 |
Why?
|
| Cephalosporins | 3 | 2022 | 18 | 0.280 |
Why?
|
| Geriatrics | 1 | 2008 | 43 | 0.280 |
Why?
|
| Feasibility Studies | 4 | 2025 | 568 | 0.280 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 377 | 0.280 |
Why?
|
| Abdomen | 1 | 2007 | 91 | 0.270 |
Why?
|
| Data Interpretation, Statistical | 3 | 2010 | 194 | 0.270 |
Why?
|
| Social Support | 1 | 2010 | 371 | 0.270 |
Why?
|
| Regression Analysis | 4 | 2020 | 498 | 0.270 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1082 | 0.270 |
Why?
|
| Exercise Tolerance | 2 | 2025 | 79 | 0.270 |
Why?
|
| Exercise | 5 | 2021 | 940 | 0.270 |
Why?
|
| Cardiotonic Agents | 2 | 2025 | 53 | 0.270 |
Why?
|
| Internal Medicine | 2 | 2007 | 160 | 0.270 |
Why?
|
| Sex Factors | 5 | 2017 | 979 | 0.260 |
Why?
|
| Medical Records | 3 | 2012 | 137 | 0.260 |
Why?
|
| Medication Systems, Hospital | 1 | 2006 | 9 | 0.260 |
Why?
|
| New England | 3 | 2019 | 273 | 0.260 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 168 | 0.260 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 266 | 0.250 |
Why?
|
| Health Care Costs | 5 | 2016 | 210 | 0.250 |
Why?
|
| Biomedical Research | 3 | 2024 | 267 | 0.250 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 42 | 0.250 |
Why?
|
| Insurance Claim Review | 3 | 2017 | 76 | 0.250 |
Why?
|
| Pandemics | 2 | 2021 | 672 | 0.250 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 108 | 0.250 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2025 | 37 | 0.240 |
Why?
|
| Family Practice | 1 | 2007 | 211 | 0.240 |
Why?
|
| Program Evaluation | 3 | 2017 | 487 | 0.240 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 99 | 0.240 |
Why?
|
| Hydrocortisone | 2 | 2020 | 193 | 0.240 |
Why?
|
| Home Care Services | 3 | 2022 | 98 | 0.240 |
Why?
|
| Hospitals, Community | 3 | 2018 | 71 | 0.230 |
Why?
|
| Breathing Exercises | 1 | 2025 | 5 | 0.230 |
Why?
|
| Biofeedback, Psychology | 1 | 2025 | 6 | 0.230 |
Why?
|
| Capnography | 1 | 2025 | 7 | 0.230 |
Why?
|
| Health Services Research | 5 | 2016 | 271 | 0.230 |
Why?
|
| Societies | 2 | 2023 | 24 | 0.230 |
Why?
|
| Research Report | 2 | 2017 | 26 | 0.230 |
Why?
|
| Etomidate | 1 | 2024 | 8 | 0.230 |
Why?
|
| Focus Groups | 3 | 2020 | 303 | 0.230 |
Why?
|
| Patient Handoff | 2 | 2016 | 35 | 0.220 |
Why?
|
| Prospective Studies | 6 | 2019 | 3285 | 0.220 |
Why?
|
| Text Messaging | 2 | 2025 | 86 | 0.220 |
Why?
|
| Motivational Interviewing | 1 | 2025 | 43 | 0.220 |
Why?
|
| Ketamine | 1 | 2024 | 38 | 0.220 |
Why?
|
| Hypolipidemic Agents | 1 | 2004 | 25 | 0.220 |
Why?
|
| Brain Ischemia | 2 | 2008 | 417 | 0.220 |
Why?
|
| SEER Program | 2 | 2024 | 74 | 0.220 |
Why?
|
| Observational Studies as Topic | 2 | 2021 | 59 | 0.210 |
Why?
|
| Malnutrition | 1 | 2024 | 42 | 0.210 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 729 | 0.210 |
Why?
|
| Pharmacists | 1 | 2025 | 126 | 0.210 |
Why?
|
| Anxiety | 2 | 2025 | 423 | 0.210 |
Why?
|
| Diagnosis-Related Groups | 2 | 2015 | 87 | 0.210 |
Why?
|
| Respiration Disorders | 1 | 2023 | 25 | 0.210 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 65 | 0.200 |
Why?
|
| Machine Learning | 1 | 2025 | 177 | 0.200 |
Why?
|
| Health Equity | 1 | 2024 | 46 | 0.200 |
Why?
|
| Restraint, Physical | 1 | 2023 | 40 | 0.200 |
Why?
|
| Patient-Centered Care | 4 | 2019 | 254 | 0.200 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 166 | 0.200 |
Why?
|
| Journalism, Medical | 1 | 2002 | 4 | 0.200 |
Why?
|
| Intention | 3 | 2019 | 67 | 0.200 |
Why?
|
| Lung Diseases | 2 | 2015 | 183 | 0.200 |
Why?
|
| Physician Executives | 1 | 2002 | 28 | 0.200 |
Why?
|
| Total Quality Management | 1 | 2002 | 56 | 0.190 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2019 | 19 | 0.190 |
Why?
|
| Ethics Committees, Research | 1 | 2002 | 32 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 95 | 0.190 |
Why?
|
| Nausea | 1 | 2003 | 111 | 0.190 |
Why?
|
| Metered Dose Inhalers | 2 | 2019 | 16 | 0.190 |
Why?
|
| State Medicine | 2 | 2013 | 12 | 0.190 |
Why?
|
| Vomiting | 1 | 2003 | 137 | 0.190 |
Why?
|
| Delayed-Action Preparations | 2 | 2014 | 114 | 0.190 |
Why?
|
| Social Segregation | 1 | 2022 | 10 | 0.190 |
Why?
|
| Vegetables | 1 | 2002 | 68 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 140 | 0.180 |
Why?
|
| Fruit | 1 | 2002 | 109 | 0.180 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 462 | 0.180 |
Why?
|
| Confidence Intervals | 2 | 2013 | 240 | 0.180 |
Why?
|
| Single-Blind Method | 2 | 2023 | 143 | 0.180 |
Why?
|
| Thoracic Diseases | 1 | 2021 | 15 | 0.170 |
Why?
|
| Vitamin B Complex | 1 | 2020 | 15 | 0.170 |
Why?
|
| Plasma Substitutes | 1 | 2020 | 5 | 0.170 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2020 | 3 | 0.170 |
Why?
|
| Musculoskeletal System | 1 | 2020 | 9 | 0.170 |
Why?
|
| Thiamine | 1 | 2020 | 21 | 0.170 |
Why?
|
| Uncertainty | 1 | 2020 | 37 | 0.170 |
Why?
|
| Academic Medical Centers | 3 | 2018 | 317 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 762 | 0.170 |
Why?
|
| Drug Labeling | 1 | 2020 | 23 | 0.170 |
Why?
|
| Fluoroquinolones | 2 | 2022 | 34 | 0.170 |
Why?
|
| Microbiological Techniques | 1 | 2020 | 5 | 0.170 |
Why?
|
| Albumins | 1 | 2020 | 35 | 0.170 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2020 | 28 | 0.170 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 264 | 0.170 |
Why?
|
| Ascorbic Acid | 1 | 2020 | 50 | 0.170 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 65 | 0.170 |
Why?
|
| Recurrence | 3 | 2015 | 641 | 0.170 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 45 | 0.170 |
Why?
|
| Symptom Flare Up | 1 | 2020 | 13 | 0.160 |
Why?
|
| Pregabalin | 1 | 2019 | 4 | 0.160 |
Why?
|
| Documentation | 1 | 2021 | 128 | 0.160 |
Why?
|
| Health Expenditures | 2 | 2012 | 122 | 0.160 |
Why?
|
| Cost Sharing | 1 | 2019 | 15 | 0.160 |
Why?
|
| Patient Preference | 2 | 2018 | 84 | 0.160 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 104 | 0.160 |
Why?
|
| Exercise Test | 1 | 2021 | 252 | 0.160 |
Why?
|
| Prescription Drug Overuse | 1 | 2019 | 7 | 0.160 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 72 | 0.160 |
Why?
|
| Preoperative Period | 1 | 2019 | 71 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 107 | 0.160 |
Why?
|
| Economics, Hospital | 2 | 2011 | 15 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 150 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 112 | 0.150 |
Why?
|
| Potassium | 1 | 2019 | 101 | 0.150 |
Why?
|
| Filing | 1 | 2019 | 3 | 0.150 |
Why?
|
| Administration, Oral | 3 | 2023 | 369 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 172 | 0.150 |
Why?
|
| Caregivers | 2 | 2025 | 271 | 0.150 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 90 | 0.150 |
Why?
|
| Snoring | 1 | 2018 | 8 | 0.150 |
Why?
|
| Spatial Analysis | 1 | 2018 | 12 | 0.150 |
Why?
|
| Analgesics | 1 | 2019 | 102 | 0.150 |
Why?
|
| Crowdsourcing | 1 | 2019 | 15 | 0.150 |
Why?
|
| Oxygen | 1 | 2020 | 315 | 0.150 |
Why?
|
| Diet | 1 | 2002 | 524 | 0.150 |
Why?
|
| Diarrhea | 1 | 2019 | 76 | 0.150 |
Why?
|
| Respiratory System | 1 | 2018 | 45 | 0.150 |
Why?
|
| Ventilators, Mechanical | 1 | 2018 | 30 | 0.150 |
Why?
|
| Hospital Charges | 1 | 2018 | 23 | 0.140 |
Why?
|
| Organizational Culture | 1 | 2019 | 110 | 0.140 |
Why?
|
| Data Warehousing | 1 | 2018 | 7 | 0.140 |
Why?
|
| Trust | 1 | 2019 | 73 | 0.140 |
Why?
|
| Social Class | 1 | 2019 | 133 | 0.140 |
Why?
|
| Models, Economic | 2 | 2015 | 44 | 0.140 |
Why?
|
| Cognitive Dysfunction | 2 | 2019 | 331 | 0.140 |
Why?
|
| Bias | 1 | 2018 | 112 | 0.140 |
Why?
|
| American Hospital Association | 1 | 2017 | 3 | 0.140 |
Why?
|
| Subacute Care | 1 | 2017 | 9 | 0.140 |
Why?
|
| Income | 2 | 2019 | 169 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 663 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2018 | 57 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 973 | 0.140 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 1146 | 0.140 |
Why?
|
| Independent Living | 1 | 2017 | 51 | 0.140 |
Why?
|
| Oregon | 1 | 2017 | 19 | 0.130 |
Why?
|
| Professional-Family Relations | 1 | 2018 | 88 | 0.130 |
Why?
|
| Hospital Bed Capacity | 3 | 2013 | 27 | 0.130 |
Why?
|
| Texas | 1 | 2017 | 57 | 0.130 |
Why?
|
| Evaluation Studies as Topic | 1 | 2017 | 104 | 0.130 |
Why?
|
| Frail Elderly | 1 | 2017 | 109 | 0.130 |
Why?
|
| Nephrology | 1 | 2017 | 15 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2018 | 268 | 0.130 |
Why?
|
| Sample Size | 1 | 2017 | 65 | 0.130 |
Why?
|
| Hemorrhage | 3 | 2016 | 267 | 0.130 |
Why?
|
| Endocarditis | 1 | 2017 | 29 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2018 | 248 | 0.130 |
Why?
|
| Home Nursing | 1 | 2016 | 21 | 0.130 |
Why?
|
| Tetracyclines | 1 | 2016 | 6 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 74 | 0.130 |
Why?
|
| Southeastern United States | 1 | 2016 | 26 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 72 | 0.130 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2016 | 11 | 0.130 |
Why?
|
| Kidney Calculi | 1 | 2017 | 34 | 0.130 |
Why?
|
| Stroke | 2 | 2021 | 1192 | 0.130 |
Why?
|
| Likelihood Functions | 1 | 2016 | 69 | 0.130 |
Why?
|
| Health Literacy | 2 | 2016 | 85 | 0.130 |
Why?
|
| Population Surveillance | 2 | 2013 | 206 | 0.130 |
Why?
|
| Medical Device Recalls | 1 | 2016 | 2 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2018 | 262 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 777 | 0.130 |
Why?
|
| Boston | 1 | 2017 | 252 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2016 | 146 | 0.120 |
Why?
|
| Data Mining | 1 | 2016 | 38 | 0.120 |
Why?
|
| Medication Reconciliation | 1 | 2016 | 13 | 0.120 |
Why?
|
| Cardiology | 2 | 2008 | 167 | 0.120 |
Why?
|
| Alcoholism | 1 | 2019 | 318 | 0.120 |
Why?
|
| Emergencies | 1 | 2016 | 120 | 0.120 |
Why?
|
| Equipment Failure | 1 | 2016 | 67 | 0.120 |
Why?
|
| Cost Control | 1 | 2015 | 24 | 0.120 |
Why?
|
| Biomarkers | 2 | 2019 | 1398 | 0.120 |
Why?
|
| ROC Curve | 1 | 2016 | 279 | 0.120 |
Why?
|
| Lung | 2 | 2017 | 946 | 0.120 |
Why?
|
| Hematoma | 1 | 2016 | 80 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2017 | 155 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 190 | 0.120 |
Why?
|
| Societies, Medical | 3 | 2024 | 379 | 0.110 |
Why?
|
| Paracentesis | 1 | 2014 | 12 | 0.110 |
Why?
|
| Ascites | 1 | 2014 | 21 | 0.110 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2014 | 33 | 0.110 |
Why?
|
| Prenatal Care | 1 | 2016 | 170 | 0.110 |
Why?
|
| Rehydration Solutions | 1 | 2014 | 3 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 205 | 0.110 |
Why?
|
| Cholinergic Antagonists | 1 | 2014 | 32 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2017 | 482 | 0.110 |
Why?
|
| Occupations | 1 | 2014 | 52 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2015 | 160 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 417 | 0.110 |
Why?
|
| Cause of Death | 1 | 2015 | 221 | 0.110 |
Why?
|
| Education | 1 | 2014 | 68 | 0.110 |
Why?
|
| Bacteremia | 1 | 2015 | 94 | 0.110 |
Why?
|
| Hospice Care | 2 | 2025 | 66 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1255 | 0.110 |
Why?
|
| Positive-Pressure Respiration | 1 | 2014 | 51 | 0.110 |
Why?
|
| Medical Audit | 1 | 2014 | 65 | 0.100 |
Why?
|
| Pamphlets | 1 | 2013 | 16 | 0.100 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 49 | 0.100 |
Why?
|
| Urban Health Services | 1 | 2013 | 14 | 0.100 |
Why?
|
| Communication Barriers | 1 | 2014 | 67 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2013 | 70 | 0.100 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 733 | 0.100 |
Why?
|
| Wheelchairs | 1 | 2013 | 8 | 0.100 |
Why?
|
| Architectural Accessibility | 1 | 2013 | 4 | 0.100 |
Why?
|
| Moving and Lifting Patients | 1 | 2013 | 16 | 0.100 |
Why?
|
| Personnel, Hospital | 1 | 2013 | 43 | 0.100 |
Why?
|
| England | 1 | 2013 | 29 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2016 | 1356 | 0.100 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2012 | 7 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2013 | 51 | 0.100 |
Why?
|
| Patient Safety | 1 | 2015 | 243 | 0.100 |
Why?
|
| Child Health Services | 1 | 2013 | 63 | 0.100 |
Why?
|
| Patient Care Management | 1 | 2012 | 30 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 860 | 0.100 |
Why?
|
| Obstetric Labor Complications | 1 | 2012 | 23 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 222 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 291 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2013 | 161 | 0.100 |
Why?
|
| Organ Dysfunction Scores | 1 | 2012 | 23 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 146 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2012 | 14 | 0.090 |
Why?
|
| Comprehension | 1 | 2013 | 138 | 0.090 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2012 | 13 | 0.090 |
Why?
|
| Diffusion of Innovation | 1 | 2012 | 58 | 0.090 |
Why?
|
| Safety | 2 | 2009 | 145 | 0.090 |
Why?
|
| Hospital Departments | 1 | 2011 | 12 | 0.090 |
Why?
|
| Chemoprevention | 1 | 2011 | 41 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2012 | 78 | 0.090 |
Why?
|
| Delphi Technique | 2 | 2024 | 101 | 0.090 |
Why?
|
| Interrupted Time Series Analysis | 2 | 2021 | 28 | 0.090 |
Why?
|
| Public Sector | 1 | 2010 | 15 | 0.090 |
Why?
|
| Medication Errors | 1 | 2011 | 109 | 0.090 |
Why?
|
| United Kingdom | 1 | 2010 | 80 | 0.080 |
Why?
|
| Confidentiality | 1 | 2010 | 55 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 96 | 0.080 |
Why?
|
| Exercise Therapy | 2 | 2021 | 104 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 91 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 319 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 3 | 2010 | 311 | 0.080 |
Why?
|
| Outsourced Services | 1 | 2010 | 3 | 0.080 |
Why?
|
| Mobility Limitation | 1 | 2010 | 49 | 0.080 |
Why?
|
| Staphylococcus aureus | 2 | 2022 | 176 | 0.080 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2010 | 34 | 0.080 |
Why?
|
| Safety Management | 1 | 2011 | 137 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 174 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2010 | 263 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2011 | 148 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2010 | 106 | 0.080 |
Why?
|
| Medication Adherence | 2 | 2022 | 202 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2010 | 77 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 175 | 0.070 |
Why?
|
| Pharmacoepidemiology | 1 | 2008 | 7 | 0.070 |
Why?
|
| Aspirin | 1 | 2009 | 171 | 0.070 |
Why?
|
| Contraindications | 1 | 2008 | 52 | 0.070 |
Why?
|
| Neurology | 1 | 2008 | 41 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2024 | 121 | 0.070 |
Why?
|
| Administration, Inhalation | 2 | 2019 | 151 | 0.070 |
Why?
|
| Job Satisfaction | 2 | 1999 | 137 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2009 | 226 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2007 | 138 | 0.070 |
Why?
|
| Societies, Hospital | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 10 | 0.070 |
Why?
|
| Vital Capacity | 2 | 2017 | 114 | 0.070 |
Why?
|
| Spirometry | 2 | 2017 | 111 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 124 | 0.060 |
Why?
|
| Forced Expiratory Volume | 2 | 2017 | 201 | 0.060 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 144 | 0.060 |
Why?
|
| Pneumococcal Vaccines | 1 | 2006 | 20 | 0.060 |
Why?
|
| Michigan | 1 | 2025 | 43 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2010 | 725 | 0.060 |
Why?
|
| Equivalence Trials as Topic | 1 | 2025 | 14 | 0.060 |
Why?
|
| Nursing Staff, Hospital | 1 | 2005 | 67 | 0.060 |
Why?
|
| Risk | 1 | 2005 | 377 | 0.060 |
Why?
|
| Fibrinolytic Agents | 2 | 2016 | 169 | 0.050 |
Why?
|
| Case Management | 1 | 2004 | 55 | 0.050 |
Why?
|
| Hospices | 1 | 2004 | 36 | 0.050 |
Why?
|
| Hypotension | 1 | 2004 | 50 | 0.050 |
Why?
|
| Knowledge | 1 | 2024 | 31 | 0.050 |
Why?
|
| Judgment | 1 | 2024 | 34 | 0.050 |
Why?
|
| Forecasting | 2 | 2002 | 232 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 149 | 0.050 |
Why?
|
| Algorithms | 2 | 2023 | 999 | 0.050 |
Why?
|
| Feedback | 1 | 2003 | 93 | 0.050 |
Why?
|
| Italy | 1 | 2022 | 66 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 70 | 0.050 |
Why?
|
| Ontario | 1 | 2022 | 45 | 0.050 |
Why?
|
| Health Policy | 2 | 2016 | 192 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2023 | 198 | 0.050 |
Why?
|
| Oseltamivir | 1 | 2022 | 35 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2004 | 509 | 0.050 |
Why?
|
| Governing Board | 1 | 2021 | 3 | 0.050 |
Why?
|
| Health Facilities | 1 | 2022 | 43 | 0.050 |
Why?
|
| Informed Consent | 1 | 2002 | 140 | 0.050 |
Why?
|
| Causality | 1 | 2021 | 58 | 0.040 |
Why?
|
| Cost Savings | 1 | 2021 | 54 | 0.040 |
Why?
|
| Blood Culture | 1 | 2020 | 10 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2020 | 46 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 66 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 421 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 363 | 0.040 |
Why?
|
| Vitamins | 1 | 2020 | 80 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 89 | 0.040 |
Why?
|
| Morphine | 1 | 2019 | 59 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 47 | 0.040 |
Why?
|
| Fees and Charges | 1 | 1999 | 17 | 0.040 |
Why?
|
| Rectum | 1 | 2019 | 89 | 0.040 |
Why?
|
| Telemedicine | 1 | 2024 | 321 | 0.040 |
Why?
|
| Liability, Legal | 1 | 2019 | 18 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 123 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 322 | 0.040 |
Why?
|
| Polysaccharides | 2 | 2011 | 144 | 0.040 |
Why?
|
| Arousal | 1 | 2018 | 42 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 2018 | 20 | 0.040 |
Why?
|
| Colon | 1 | 2019 | 146 | 0.040 |
Why?
|
| Polysomnography | 1 | 2018 | 57 | 0.040 |
Why?
|
| Medicine | 1 | 1999 | 57 | 0.040 |
Why?
|
| Patient Simulation | 1 | 2019 | 72 | 0.040 |
Why?
|
| Social Theory | 1 | 2018 | 7 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 690 | 0.040 |
Why?
|
| Physician Incentive Plans | 1 | 1998 | 9 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 99 | 0.040 |
Why?
|
| Inventories, Hospital | 1 | 2017 | 3 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 1998 | 38 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2018 | 47 | 0.030 |
Why?
|
| Demography | 1 | 1998 | 173 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 1998 | 66 | 0.030 |
Why?
|
| Chicago | 1 | 2017 | 27 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2017 | 4 | 0.030 |
Why?
|
| Self Administration | 1 | 2016 | 48 | 0.030 |
Why?
|
| Health Priorities | 1 | 2016 | 28 | 0.030 |
Why?
|
| Psychological Theory | 1 | 2016 | 26 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 163 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 22 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2016 | 78 | 0.030 |
Why?
|
| Cancer Survivors | 1 | 2018 | 115 | 0.030 |
Why?
|
| General Practice | 1 | 2016 | 16 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 62 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 60 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 68 | 0.030 |
Why?
|
| North Carolina | 1 | 2016 | 70 | 0.030 |
Why?
|
| Shock | 1 | 2016 | 33 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 66 | 0.030 |
Why?
|
| Counseling | 1 | 2018 | 362 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 200 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 275 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 131 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2017 | 289 | 0.030 |
Why?
|
| Telecommunications | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 183 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 272 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 435 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2014 | 93 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 469 | 0.030 |
Why?
|
| Social Behavior | 1 | 2014 | 90 | 0.030 |
Why?
|
| Medical Waste | 1 | 2013 | 3 | 0.030 |
Why?
|
| Fatigue | 1 | 2014 | 111 | 0.030 |
Why?
|
| Conservation of Energy Resources | 1 | 2013 | 6 | 0.030 |
Why?
|
| Time Management | 1 | 2013 | 9 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 544 | 0.030 |
Why?
|
| Photography | 1 | 2013 | 41 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2014 | 345 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 2012 | 39 | 0.020 |
Why?
|
| Multi-Institutional Systems | 1 | 2012 | 5 | 0.020 |
Why?
|
| Psychometrics | 1 | 2014 | 376 | 0.020 |
Why?
|
| Stockings, Compression | 1 | 2011 | 1 | 0.020 |
Why?
|
| Depression | 1 | 2018 | 892 | 0.020 |
Why?
|
| Sleep | 1 | 2014 | 224 | 0.020 |
Why?
|
| Mental Health | 1 | 2014 | 371 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 74 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 123 | 0.020 |
Why?
|
| Patient Rights | 1 | 2010 | 15 | 0.020 |
Why?
|
| Developed Countries | 1 | 2010 | 16 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 44 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 44 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 293 | 0.020 |
Why?
|
| Developing Countries | 1 | 2010 | 94 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 140 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 111 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 596 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 573 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 2002 | 36 | 0.010 |
Why?
|
| Institutional Practice | 1 | 2000 | 3 | 0.010 |
Why?
|
| Bed Occupancy | 1 | 1999 | 12 | 0.010 |
Why?
|